Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:abusePotential |
low
|
| gptkbp:actsOn |
serotonin receptor agonist
serotonin releasing agent |
| gptkbp:CASNumber |
6640-24-0
|
| gptkbp:contains_functional_group |
gptkb:piperazine
chlorophenyl |
| gptkbp:discoveredIn |
1970s
|
| gptkbp:drugClass |
recreational drug
serotonergic drug |
| gptkbp:hasInChIKey |
JZKJUVRTGDXQPN-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C10H13ClN2
|
| gptkbp:hasSMILES |
Clc1cccc(c1)N2CCNCC2
|
| https://www.w3.org/2000/01/rdf-schema#label |
mCPP
|
| gptkbp:IUPACName |
gptkb:1-(3-chlorophenyl)piperazine
|
| gptkbp:legalStatus |
varies by country
|
| gptkbp:metabolism |
gptkb:nefazodone
gptkb:trazodone |
| gptkbp:molecularWeight |
196.68 g/mol
|
| gptkbp:otherName |
gptkb:3-chlorophenylpiperazine
gptkb:meta-chlorophenylpiperazine |
| gptkbp:parent |
phenylpiperazine
|
| gptkbp:sideEffect |
nausea
anxiety headache insomnia dysphoria |
| gptkbp:usedAs |
recreational drug
research chemical |
| gptkbp:bfsParent |
gptkb:BZP
gptkb:Nefazodone gptkb:nefazodone |
| gptkbp:bfsLayer |
7
|